Seguir
Xurxo García-Otero
Xurxo García-Otero
Pharmacology, Pharmacy and Pharmaceutical Technology Department. University of Santiago de
Dirección de correo verificada de rai.usc.es
Título
Citado por
Citado por
Año
Drug delivery to the posterior segment of the eye: biopharmaceutic and pharmacokinetic considerations
R Varela-Fernández, V Díaz-Tomé, A Luaces-Rodríguez, ...
Pharmaceutics 12 (3), 269, 2020
2972020
Lactoferrin-loaded nanostructured lipid carriers (NLCs) as a new formulation for optimized ocular drug delivery
R Varela-Fernández, X García-Otero, V Díaz-Tomé, U Regueiro, ...
European Journal of Pharmaceutics and Biopharmaceutics 172, 144-156, 2022
702022
Ophthalmic econazole hydrogels for the treatment of fungal keratitis
V Díaz-Tomé, A Luaces-Rodríguez, J Silva-Rodríguez, S Blanco-Dorado, ...
Journal of pharmaceutical sciences 107 (5), 1342-1351, 2018
572018
3D printed tacrolimus rectal formulations ameliorate colitis in an experimental animal model of inflammatory bowel disease
I Seoane-Viaño, N Gómez-Lado, H Lázare-Iglesias, X García-Otero, ...
Biomedicines 8 (12), 563, 2020
542020
Design, optimization, and characterization of lactoferrin-loaded chitosan/TPP and chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a pharmacological alternative for …
R Varela-Fernandez, X Garcia-Otero, V Diaz-Tome, U Regueiro, ...
ACS Applied Materials & Interfaces 13 (3), 3559-3575, 2021
522021
Development and characterization of a tacrolimus/hydroxypropyl-β-cyclodextrin eye drop
X García-Otero, V Díaz-Tomé, R Varela-Fernández, M Martín-Pastor, ...
Pharmaceutics 13 (2), 149, 2021
302021
In situ forming and mucoadhesive ophthalmic voriconazole/HPβCD hydrogels for the treatment of fungal keratitis
V Díaz-Tomé, X García-Otero, R Varela-Fernández, M Martín-Pastor, ...
International journal of pharmaceutics 597, 120318, 2021
272021
Preclinical characterization and clinical evaluation of tacrolimus eye drops
A Luaces-Rodriguez, R Tourino-Peralba, I Alonso-Rodriguez, ...
European Journal of Pharmaceutical Sciences 120, 152-161, 2018
232018
Mucoadhesive PLGA nanospheres and nanocapsules for lactoferrin controlled ocular delivery
R Varela-Fernández, X García-Otero, V Díaz-Tomé, U Regueiro, ...
Pharmaceutics 14 (4), 799, 2022
192022
Anti-inflammatory effect of tacrolimus/hydroxypropyl-β-cyclodextrin eye drops in an endotoxin-induced uveitis model
X García-Otero, C Mondelo-García, F González, R Perez-Fernandez, ...
Pharmaceutics 13 (10), 1737, 2021
92021
Compression pressure-induced synergy in xanthan and locust bean gum hydrogels. Effect in drug delivery
M Gago-Guillán, X García-Otero, S Anguiano-Igea, FJ Otero-Espinar
Journal of Drug Delivery Science and Technology 89, 105025, 2023
72023
Antifungal Combination Eye Drops for Fungal Keratitis Treatment
V Díaz-Tomé, C Bendicho-Lavilla, X García-Otero, R Varela-Fernández, ...
Pharmaceutics 15 (1), 35, 2022
72022
PET study of intravitreal adalimumab pharmacokinetics in a uveitis rat model
X García-Otero, C Mondelo-García, E Bandín-Vilar, N Gómez-Lado, ...
International Journal of Pharmaceutics 627, 122261, 2022
72022
Drug delivery to the posterior segment of the eye: Biopharmaceutic and pharmacokinetic considerations. Pharmaceutics. 2020; 12 (3): 269
R Varela-Fernández, V Díaz-Tomé, A Luaces-Rodríguez, ...
7
3D printed tacrolimus rectal formulations ameliorate colitis in an experimental animal model of inflammatory bowel disease. Biomedicines 2020; 8: 563
I Seoane-Viaño, N Gómez-Lado, H Lázare-Iglesias, X García-Otero, ...
6
Biopharmaceutical assessment of dexamethasone acetate-based hydrogels combining hydroxypropyl cyclodextrins and polysaccharides for ocular delivery
R Mazet, X García-Otero, L Choisnard, D Wouessidjewe, V Verdoot, ...
Pharmaceutics 12 (8), 717, 2020
52020
Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems: Stability and Ocular Biopermanence
A Castro-Balado, E Bandín-Vilar, A Cuartero-Martínez, ...
Pharmaceutics 14 (10), 2194, 2022
42022
Anti-Inflammatory Effect of Tacrolimus/Hydroxypropyl-β-Cyclodextrin Eye Drops in an Endotoxin-Induced Uveitis Model. Pharmaceutics 2021, 13, 1737
X Garcia-Otero, C Mondelo-Garcia, F Gonzalez, R Perez-Fernandez, ...
s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021
32021
Preclinical characterization of endotoxin-induced uveitis models using OCT, PET/CT and proteomics
A Cuartero-Martínez, X García-Otero, J Codesido, N Gómez-Lado, ...
International Journal of Pharmaceutics 662, 124516, 2024
12024
Biodistribution and pharmacokinetics of [89Zr]-anti-VEGF mAbs using PET in glioblastoma rat models
L García-Varela, J Codesido, A Perez-Pedrosa, M Muñoz-González, ...
International Journal of Pharmaceutics 652, 123795, 2024
12024
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20